Reply to ‘Comment on: Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizmab’
Crossref DOI link: https://doi.org/10.1038/eye.2016.6
Published Online: 2016-02-12
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Papakostas, T D
Vavvas, D
Eliott, D
Kim, L A
Text and Data Mining valid from 2016-02-12
Article History
First Online: 12 February 2016
Competing interests
: The authors declare no conflict of interest.